Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 333

Results For "EY"

3996 News Found

India’s first mRNA vaccine should be ready soon
News | February 11, 2022

India’s first mRNA vaccine should be ready soon

It is being developed by Pune-based Gennova Biopharmaceuticals


Zimmer Biomet opens customer experience centre in Singapore to drive robotics and MedTech
Medical Device | February 11, 2022

Zimmer Biomet opens customer experience centre in Singapore to drive robotics and MedTech

It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants


TATA MD’s OmiSure detects all Omicron variants
Medical Device | February 09, 2022

TATA MD’s OmiSure detects all Omicron variants

According to ICMR, the upgraded OmiSure RT-PCR test for Covid-19 successfully detects all sub-types of Omicron that are currently prevalent in India


EdiGene and Neukio collaborate to develop next-generation immune cell therapies
Biotech | February 09, 2022

EdiGene and Neukio collaborate to develop next-generation immune cell therapies

The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)


Strand Therapeutics appoints Dr. Prashant Nambiar as Senior VP
People | February 09, 2022

Strand Therapeutics appoints Dr. Prashant Nambiar as Senior VP

Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics


Piramal Pharma Solutions plans expansion in Scotland
News | February 09, 2022

Piramal Pharma Solutions plans expansion in Scotland

In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three


Abbott announces world's first implant of dual-chamber leadless pacemaker in pivotal trial
Medical Device | February 08, 2022

Abbott announces world's first implant of dual-chamber leadless pacemaker in pivotal trial

Proprietary implant-to-implant (i2i) device technology is used for communication between two implanted leadless pacemakers to regulate the heart rate


Biogen and Xbrane announce commercialization and license agreement for biosimilar to treat rheumatoid arthritis
Biotech | February 08, 2022

Biogen and Xbrane announce commercialization and license agreement for biosimilar to treat rheumatoid arthritis

Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane


Wockhardt gets CDSCO nod to export 100 million doses of Sputnik vaccines
News | February 08, 2022

Wockhardt gets CDSCO nod to export 100 million doses of Sputnik vaccines

Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19


Merck KGaA restructures life science business to support long-term growth
News | February 08, 2022

Merck KGaA restructures life science business to support long-term growth

Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services